AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
February 24, 2023Business Services
LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …
Sanofi and Glooko partner on ‘connected insulin’ tech
February 24, 2023Medical Communications
Big pharma company Sanofi aims to develop insulin-based therapies that can be connected with glucose monitoring devices, making it easier …
Mologic Inc’s COVID-19 rapid antigen self-test receives FDA Emergency Use Authorization for home use
February 24, 2023Medical Communications
US subsidiary of Global Access Diagnostics (GADx) ‒ a developer of lateral flow and rapid diagnostic technologies, products and services …
NICE approved BMS’s Opdivo for lung cancer
February 24, 2023Medical Communications
Bristol-Myers Squibb’s (BMS) immunotherapy drug Opdivo (nivolumab) has become the first to be cleared for NHS use alongside chemotherapy as …
Moda Living and LloydsPharmacy partner to offer residents prescription service
February 24, 2023Medical Communications
Moda Living has announced a partnership with LloydsPharmacy to bring residents a ‘Health Concierge Service’ through VideoGP. VideoGP will …
UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency
February 23, 2023Business Services
February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …
NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer
February 23, 2023Business Services
(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …
LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN
February 23, 2023Business Services
Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …
Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
February 23, 2023Business Services
Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …
8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline
February 23, 2023Business Services
LONDON 23rd February 2023
BiomX shares positive data from first bacteriophage trial
February 23, 2023Research and Development
BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …
Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics
February 23, 2023Research and Development
UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …
AstraZeneca signs $63m agreement for gastric cancer treatment
February 23, 2023Medical Communications
AstraZeneca has announced that it has signed an exclusive license agreement (ELA) with KYM Biosciences Inc for CMG901, which is …
£1.6bn of research and development funding “surrendered” back to UK Treasury
February 23, 2023Medical Communications
A pot of £1.6bn which was originally allocated as the UK’s contribution to the €96bn Horizon Europe research funding programme …
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
February 22, 2023Business Services
Nantes, France – February 22, 2023, 6:00 p.m.
Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug
February 22, 2023Research and Development
Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …
FDA grants approval to Beckley Psytech’s short-acting psychedelic trial
February 22, 2023Research and Development
Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …
PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA
February 22, 2023Business Services
BASILDON, UK, 22 February 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
February 22, 2023Business Services
London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
Latest content
FibroFind appoints Lee Borthwick as CEO
